Akt phosphorylation at these two sites has been associated with decreased overall survival in several studies [46,82,96], though independently, increased PI3K-Akt activity may constitute a favorable prognostic factor in AML [95]. This evidence concerns the gene PIK3CD and acute myeloid leukemia.